Enoxaparin versus unfractionated heparin in the prevention of venous thromboembolism after acute ischemic stroke: Rationale, design, and methods of an open-label, randomized, parallel-group multicenter trial

Journal of Stroke and Cerebrovascular Diseases

Volumn 14, Issue 3, 2005, Pages 95-100

  Sherman, David G ^a,c   Soltes, Sandor ^b   Samuel, Rita ^b   Chibedi Deroche, Daniela ^b  

^a University of Texas Health Science Center at San Antonio   (United States)

^b SANOFI   (France)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Acute; Enoxaparin; Heparin; Prophylaxis (deep vein thrombosis); Stroke; Thromboembolism

Indexed keywords

CONTRAST MEDIUM; ENOXAPARIN; HEPARIN;

ALGORITHM; ARM; ARTICLE; B SCAN; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG USE; EPIDURAL HEMATOMA; FEMALE; FOLLOW UP; HEALTH CARE PLANNING; HEALTH ECONOMICS; HOSPITALIZATION; HUMAN; INCIDENCE; LEG; LEG PHLEBOGRAPHY; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL DOCUMENTATION; MULTICENTER STUDY; PARALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; SYMPTOM; THROMBOCYTOPENIA; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 18344376187     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2004.12.008     Document Type: Article

References (35)

1. J. Broderick, T. Brott, R. Kothari The greater Cincinnati/Northern Kentucky stroke study Preliminary first-ever and total incidence rates of stroke among blacks Stroke 29 1998 415 421
2. G.R. Williams, J.G. Jiang, D.B. Matchar Incidence and occurrence of total (first-ever and recurrent) stroke Stroke 30 1999 2523 2528
3. K.C. Johnston, J.Y. Li, P.D. Lyden Medical and neurological complications of ischemic stroke Experience from the RANTTAS trial; RANTTAS investigators Stroke 29 1998 447 453
4. A.G. Turpie Prophylaxis of venous thromboembolism in stroke patients Semin Thromb Hemost 23 1997 155 157
5. S.T. McCarthy, J. Turner Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke Age Ageing 15 1986 84 88
6. W.H. Geerts, J.A. Heit, G.P. Clagett Prevention of venous thromboembolism Chest 119 suppl 2001 132S 175S
7. J. Kelly, A. Rudd, R. Lewis Venous thromboembolism after acute stroke Stroke 32 2001 262 267
8. R. Dumas, F. Woitinas, M. Kutnowski A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischemic stroke Age Ageing 23 1994 512 516
9. M. Hillbom, T. Erila, C. Flosbach Enoxaparin, a low-molecular weight heparin is superior to heparin in the prevention of deep-vein thrombosis in stroke patients Stroke 29 1999 304
10. A.G. Turpie, M. Gent, R. Cote A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke A randomized, double-blind study Ann Intern Med 117 1992 353 357
11. B. Birdwell Recent clinical trials in the diagnosis of deep-vein thrombosis Curr Opin Hematol 6 1999 275 279
12. M.P. Gomes, S.R. Deitcher Diagnosis of venous thromboembolic disease in cancer patients Oncology (Huntingt) 17 2003 126 135 139-144
13. T. Brott, H.P. Adams Jr, C.P. Olinger Measurements of acute cerebral infarction A clinical examination scale Stroke 20 1989 864 870
14. R. Bonita, R. Beaglehole Recovery of motor function after stroke Stroke 19 1988 1497 1500
15. A.W. Lensing, H.R. Buller, P. Prandoni Contrast venography, the gold standard for the diagnosis of deep-vein thrombosis Improvement in observer agreement Thromb Haemost 67 1992 8 12
16. K. Rabinov, S. Paulin Roentgen diagnosis of venous thrombosis in the leg Arch Surg 104 1972 134 144
17. V.F. Tapson, B.A. Carroll, B.L. Davidson The diagnostic approach to acute venous thromboembolism: Clinical practice guideline; American Thoracic Society Am J Respir Crit Care Med 160 1999 1043 1066
18. The PIOPED Investigators Value of the ventilation perfusion scan in acute pulmonary embolism Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED) JAMA 263 1990 2753 2759
19. D.A. Grimes, K.F. Schulz Determining sample size and power in clinical trials The forgotten essential Semin Reprod Endocrinol 14 1996 125 131
20. S.N. Goodman, J.A. Berlin The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results Ann Intern Med 121 1994 200 206
21. D.M. Reboussin, D.L. DeMets, K.M. Kim Computations for group sequential boundaries using the Lan-DeMets spending function method Control Clin Trials 21 2000 190 207
22. K.K. Lan, W.F. Rosenberger, J.M. Lachin Use of spending functions for occasional or continuous monitoring of data in clinical trials Stat Med 12 1993 2219 2231
23. S.C. Choi Interim analyses and early termination of clinical trials J Biopharm Stat 7 1997 533 543
24. S.C. Choi, Y.J. Lee Interim analyses with delayed observations in clinical trials Stat Med 18 1999 1297 1306
25. S.M. Lai, P.W. Duncan Stroke recovery profile and the modified Rankin assessment Neuroepidemiology 20 2001 26 30
26. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
27. P.M. Bath, R. Iddenden, F.J. Bath Low-molecular-weight heparins and heparinoids in acute ischemic stroke A meta-analysis of randomized controlled trials Stroke 31 2000 1770 1778
28. G.W. Albers, P. Amarenco, J.D. Easton Antithrombotic and thrombolytic therapy for ischemic stroke Chest 119 suppl 2001 300S 320S
29. S.T. McCarthy, J.J. Turner, D. Robertson Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke Lancet 2 1977 800 801
30. A.G. Turpie, M.N. Levine, J. Hirsh Double-blind randomized trial of ORG 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke Lancet 1 1987 523 526
31. M.H. Prins, R. Gelsema, A.K. Sing Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients Haemostasis 19 1989 245 250
32. P.M. Sandset, T. Dahl, M. Stiris A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke Semin Thromb Hemost 16 1990 25 33
33. N.R. Bijsterveld, R. Hettiarachchi, R. Peters Low-molecular weight heparins in venous and arterial thrombotic disease Thromb Haemost 82 1999 139 147
34. C. Counsell, P. Sandercock Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke Cochrane Database Syst Rev 4 2001 CD000119
35. R.L. Sacco Design considerations in stroke clinical trials International stroke trial and warfarin aspirin recurrent stroke study J. Grotta L.P. Miller A.M. Buchan Ischemic stroke Recent advances in understanding and therapy 1995 International Business Communications Inc Southborough 2 29